期刊文献+

盐酸托泊替康质量分析方法研究 被引量:4

Methods for the Quality Control of Topotecan Hydrochloride
下载PDF
导出
摘要 对盐酸托泊替康的有关物质、含量测定两个项目进行研究。采用HPLC,使用C18柱,流动相为体积分数0.59/6三乙胺溶液和质量分数0.0432%的十二烷基硫酸钠(用磷酸调节PH4.0)-甲醇(50:50),波长267nm。结果显示,本品在0.008~0.072mg/mL范围内线性关系良好,回归方程为A=272671ρ-1653.2(r=0.999,n=5),平均回收率不低于99.2%,与降解产物和中间品有较好的分离,溶液8h内稳定,故可知所建立的分析方法专属性强、灵敏度高,测定结果准确可靠,适用于盐酸托泊替康的质量控制。 Related substance and contents of topotecan hydrochloride were studied. The separa- tion was performed in the C18 column, and the mobile phase consisted of 0.5% triethylamine and 0. 043 2% sodium dodecyl sulfate (adjusted the solution with phosphoric acid to pH 4.0 )-methanol (50:50)with the detection wavelength of 267 nm. The calibration curves were linear in the ranges of 0. 008-0. 072 mg/mL, and the average recoveries were not less than 99.2%0. Topotecan hydrochloride and related substances could be separated well. Samples were stable in 8hrs. The methods were proved to be accurate and reliable with high selectivity, sensitivity and repro-ducibility, and were suitable for the quality control of topotecan hydrochloride.
作者 周健 蒋锋
出处 《淮海工学院学报(自然科学版)》 CAS 2011年第1期55-57,共3页 Journal of Huaihai Institute of Technology:Natural Sciences Edition
关键词 盐酸托泊替康 质量控制 HPLC topotecan hydrochloride quality control HPLC
  • 相关文献

参考文献6

二级参考文献38

  • 1秦海霞,南克俊,杨光.三种方案治疗晚期大肠癌近期疗效比较[J].中国癌症杂志,2004,14(3):265-267. 被引量:4
  • 2梅同华,徐小杰.TP与NP方案治疗晚期非小细胞肺癌的疗效比较[J].中国药房,2005,16(2):127-128. 被引量:15
  • 3郭舜民.喜树碱类似物的研究进展[J].国外医学(药学分册),1994,21(5):270-273. 被引量:6
  • 4张红,童明容,潘继伦,俞耀庭,王永耀,黄杏林,黄加斗,胡雄军.大孔吸附树脂提取喜树碱的研究[J].离子交换与吸附,1995,11(2):145-150. 被引量:43
  • 5张家麟.药物临床信息参考[M].成都:四川科学技术出版社,2006:937-938.
  • 6[1]Schwarz EL,Roberts WL,Pasquali M,Analysis of plasma amino acids by HPLC with photodiode array and fluorescence detection,Clin Chim Acta,2005,354(1-2):83.
  • 7Brogden RN, Wiseman LR. Topotecan: a review of potential in advanced ovarian cancer[J] .Drugs, 1998,56(4):709-723.
  • 8Kingsbury WD, Boehm J C,Jakas DR, et al. Sythesis of water-soluble (Aminoalkyl) camptothecin analogues: inhibition of topoisomerase I and antitumor aetivity[J]. J Med Chem, 1991,34 (1):98-107.
  • 9Lackey K, Stembach DD, Croom DK, et al. Water soluble inhibitors of topoisomerase I: quaternary salt derivatives of camp-tothecin[J] .J Meal Chem, 1996,39(3):713-719.
  • 10Beijnen JH, Smith BR, Keijer WJ, et al. High - performance liquid chromatographic analysis of the new antitumour drug SK&F 104864 -A(NSC609699) in plasma. J Pharm Biomed Anal,1990,8:789.

共引文献17

同被引文献17

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部